Schrodinger Inc. Company Profile
NASDAQ: SDGRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 26.96 -1.21%
Schrodinger at a glance
Schrodinger Inc. (NASDAQ: SDGR) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in New York, NY. Schrodinger is led by Dr. Ramy Farid Ph.D. and employs about 850 people. The company's shares have traded publicly since 2020.
At a market capitalization of $2.04 billion, it is considered a mid-cap company. Its SEC Central Index Key (CIK) is 0001490978, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Schrodinger do?
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Business description based on the company's public filings.
Company information
- Legal name
- Schrodinger Inc.
- Ticker
- NASDAQ: SDGR
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. Ramy Farid Ph.D.
- Employees
- 850
- Headquarters
- 1540 Broadway, New York, NY, United States
- Phone
- 212 295 5800
- Website
- schrodinger.com
- IPO year
- 2020
- Market cap
- $2.04B
- SEC CIK
- 0001490978
Companies similar to Schrodinger
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PRGOPerrigo Company plc | 14.55 | +3.93% | $2.01B | vs SDGR |
| VRDNViridian Therapeutics Inc. | 18.28 | +0.33% | $2.07B | vs SDGR |
| LKFTLakefront Biotherapeutics ADR | 30.00 | +2.32% | $1.96B | vs SDGR |
| MLYSMineralys Therapeutics Inc. | 22.09 | +0.64% | $1.95B | vs SDGR |
| ZYMEZymeworks Inc. | 26.53 | +3.43% | $1.90B | vs SDGR |
| VERAVera Therapeutics Inc. Class A | 30.25 | +2.82% | $2.18B | vs SDGR |
| GPCRStructure Therapeutics Inc. ADR | 26.68 | -2.88% | $1.90B | vs SDGR |
| AGIOAgios Pharmaceuticals Inc. | 31.79 | +0.22% | $1.90B | vs SDGR |